Viralytics has been granted an Australian patent covering the use of Echoviruses for the treatment of all cancers bearing expression of the integrin α2β1.
45516
Viralytics granted Australian patent for echoviruses for treatment of cancers
175596
Compugen discovers cancer treatment target
59485
Consortium supports next generation drug discovery
78355
BioAmber secures $45 million in venture capital
119899
AVI Biopharma secures increased funding of approximately $4.0 million
173138
Milestone Scientific acquires additional patent rights for painless injections
168298
NEW treatment regime offers hope to cancer patients
33971
Motavizumab should not be licensed for marketing:
14521
Animetrics awarded new patents
69306
The Echo Nest secures additional venture financing
63912
Breakthrough could nip arthritis in the bud
123319
IBM helps researchers search for cure for the common cold
52265
Breast cancer vaccine shows promising results
36860
Carestream Health assigned patent
57885
Symposium on targeted cancer therapy, Heidelberg, Germany
97434
Amicus Therapeutics initiates trial of AT2220 in Pompe disease
25549
Scientists working on a new cancer drug